![]() |
|
|
3 Lipids and Atherosclerosis Research Unit, Reina Sofía University Hospital, Córdoba, and Ciber Fisiopatología Obesidad y Nutrición (CB06/03) Instituto de Salud Carlos III, 14004 Madrid, Spain and 4 Jean Mayer-USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111-1524
* To whom correspondence should be addressed. E-mail: jlopezmir{at}uco.es.
Apolipoprotein (Apo) A-II is an apolipoprotein with an unknown role in lipid metabolism. It has been suggested that the presence of the less frequent allele of a single nucleotide polymorphism (Apo A-II -265T/C, rs5082) reduces the transcription rate of Apo A-II and enhances VLDL postprandial clearance in middle-aged men. To further investigate the role of Apo A-II -265T/C on lipid metabolism, we studied 88 normolipidemic young men. The participants were given a fatty meal containing 1 g fat and 7 mg cholesterol/kg weight and capsules containing 60,000 IU vitamin A (retinyl palmitate, 15.15 mg RE) per square meter body surface area. Postprandial lipemia was assessed during the 11 h following the meal. Total cholesterol (Chol) and triacylglycerols (TG) in plasma and TG-rich lipoproteins (TRL) (large TRL and small TRL) were measured, as well as HDL, Apo A-I, Apo B, Apo B-48, and Apo B-100. Postprandial responses were higher in the TT group than in carriers of the minor allele (CC/TC) for total TG in plasma (21.37% of change of area under curve, P = 0.014), large TRL-TG (24.75% change, P = 0.017) and small TRL-Chol (26.63% change, P = 0.003). Our work shows that carriers of the minor allele for Apo A-II -265T/C (CC/TC) have a lower postprandial response compared with TT homozygotes. This finding may partially explain the role of Apo A-II in lipid metabolism and can identify a population with a decreased risk of cardiovascular disease, as corresponds to the lower level of postprandial hypertriglyceridemia.
This article has been cited by other articles:
![]() |
J. Julve, J. C. Escola-Gil, N. Rotllan, C. Fievet, E. Vallez, C. de la Torre, V. Ribas, J. H. Sloan, and F. Blanco-Vaca Human Apolipoprotein A-II Determines Plasma Triglycerides by Regulating Lipoprotein Lipase Activity and High-Density Lipoprotein Proteome Arterioscler Thromb Vasc Biol, February 1, 2010; 30(2): 232 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Delgado-Lista, F. Perez-Jimenez, J. Ruano, P. Perez-Martinez, F. Fuentes, J. Criado-Garcia, L. D Parnell, A. Garcia-Rios, J. M Ordovas, and J. Lopez-Miranda Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men J. Lipid Res., January 1, 2010; 51(1): 63 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Castellani, C. N. Nguyen, S. Charugundla, M. M. Weinstein, C. X. Doan, W. S. Blaner, N. Wongsiriroj, and A. J. Lusis Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance J. Biol. Chem., April 25, 2008; 283(17): 11633 - 11644. [Abstract] [Full Text] [PDF] |
||||